These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8169748)

  • 1. Mutations in familial cancer.
    Wright PA; Wynford-Thomas D
    J Pathol; 1994 Feb; 172(2):167-70. PubMed ID: 8169748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Predictive testing for p53-mutations; ethical considerations. National Work Group Hereditary Mamma Carcinoma].
    de Wert GM
    Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1350-3. PubMed ID: 8710023
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
    Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
    Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
    Menko FH; Nooy MA; Vasen HF
    Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer. A deadly inheritance.
    Vogelstein B
    Nature; 1990 Dec 20-27; 348(6303):681-2. PubMed ID: 2259380
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer genetics.
    Knudson AG
    Am J Med Genet; 2002 Jul; 111(1):96-102. PubMed ID: 12124744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
    Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF
    Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer.
    Carneiro F; Oliveira C; Suriano G; Seruca R
    J Clin Pathol; 2008 Jan; 61(1):25-30. PubMed ID: 17513507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.
    Richards ML
    Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 tumor-suppressor gene.
    Levine AJ
    N Engl J Med; 1992 May; 326(20):1350-2. PubMed ID: 1565147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Knudson's "two-hit" hypothesis in familial cancer syndromes].
    Hino O
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):924-9. PubMed ID: 9212799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
    Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
    Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic factors involved in cancer susceptibility].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to colorectal cancer.
    de la Chapelle A
    Nat Rev Cancer; 2004 Oct; 4(10):769-80. PubMed ID: 15510158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.
    Kovar H; Auinger A; Jug G; Aryee D; Zoubek A; Salzer-Kuntschik M; Gadner H
    Oncogene; 1993 Oct; 8(10):2683-90. PubMed ID: 8378080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics and management strategies in hereditary cancer syndromes.
    Hanna NN; Mentzer RM
    J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes.
    Cortesi L; Turchetti D; Bertoni C; Zanocco-Marani T; Vinceti M; Silvestri C; Federico M; Silingardi V; Ferrari S
    Eur J Hum Genet; 2003 Mar; 11(3):210-4. PubMed ID: 12673274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The molecular diagnosis of cancer].
    Barrera Saldaña H; Martínez Garza S; Ortiz López R
    Rev Invest Clin; 2003; 55(2):128-37. PubMed ID: 12827915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.